Literature DB >> 12834101

Awareness and use of osteopathic physicians in the United States: results of the Second Osteopathic Survey of Health Care in America (OSTEOSURV-II).

John C Licciardone1.   

Abstract

The Second Osteopathic Survey of Health Care in America (OSTEOSURV-II), a national telephone survey conducted during 2000 using random-digit dialing, was used to address questions about public awareness of the osteopathic medical profession and use of osteopathic physicians. A total of 499 adult, noninstitutionalized, household respondents were surveyed. The main outcomes included prevalence of and multivariate factors associated with awareness and use of osteopathic physicians. The overall response rate was 64%. The prevalence of awareness, lifetime use, and current use of osteopathic physicians among unscreened respondents was 46%, 16%, and 7%, respectively. Among lifetime users, 84% received primary care; 52%, osteopathic manipulative treatment; and 25%, specialty care. The multivariate factors most strongly associated with awareness of osteopathic physicians were college education (rate ratio [RR], 1.86; 95% confidence interval [CI], 1.43-2.40), 60 or more years of age (RR, 1.52; 95% CI, 1.15-2.01), and Midwest residence (RR, 1.39; 95% CI, 1.05-1.84). Nonwhites, including Hispanics, were less likely to be aware of osteopathic physicians (RR, 0.54; 95% CI, 0.38-0.76). Respondents with college education (RR, 2.34; 95% CI, 1.44-3.79), respondents of intermediate age (RR, 1.71; 95% CI, 1.12-2.61), and women (RR, 1.68; 95% CI, 1.12-2.52) were more likely to report lifetime use of osteopathic physicians. Nonwhites were less likely to report lifetime use (RR, 0.25; 95% CI, 0.11-0.57). Greater promotional efforts are needed to increase awareness of osteopathic medicine and to remove barriers to using osteopathic physicians, particularly among nonwhites.

Entities:  

Mesh:

Year:  2003        PMID: 12834101

Source DB:  PubMed          Journal:  J Am Osteopath Assoc        ISSN: 0098-6151


  8 in total

1.  Sociodemographic and geographic characteristics associated with patient visits to osteopathic physicians for primary care.

Authors:  John C Licciardone; Karan P Singh
Journal:  BMC Health Serv Res       Date:  2011-11-04       Impact factor: 2.655

Review 2.  Osteopathic manipulative treatment for low back pain: a systematic review and meta-analysis of randomized controlled trials.

Authors:  John C Licciardone; Angela K Brimhall; Linda N King
Journal:  BMC Musculoskelet Disord       Date:  2005-08-04       Impact factor: 2.362

3.  A comparison of patient visits to osteopathic and allopathic general and family medicine physicians: results from the National Ambulatory Medical Care Survey, 2003-2004.

Authors:  John C Licciardone
Journal:  Osteopath Med Prim Care       Date:  2007-01-12

4.  Osteopathic research: elephants, enigmas, and evidence.

Authors:  John C Licciardone
Journal:  Osteopath Med Prim Care       Date:  2007-02-08

5.  Assessing the Knowledge of the Osteopathic Profession in New York City's Eastern European Communities.

Authors:  Justin Chin; Lina Kleyn; Emily Dube; Mark Terrell; Christine M Lomiguen; Mikhail Volokitin
Journal:  Cureus       Date:  2022-01-27

6.  Exploring New Patient Understanding of Osteopathic Manipulative Medicine using a Cross-Sectional Survey and Mixed Methods Approach.

Authors:  Jared Ham-Ying; Samuel J Wisniewski; Jake Rowan; Izabela Birsanescu; Alicia Speak; Rebecca Malouin
Journal:  Spartan Med Res J       Date:  2022-09-06

7.  OSTEOPAThic Health outcomes in chronic low back pain: The OSTEOPATHIC Trial.

Authors:  John C Licciardone; Hollis H King; Kendi L Hensel; Daniel G Williams
Journal:  Osteopath Med Prim Care       Date:  2008-04-25

8.  Perceptions of the osteopathic profession in New York City's Chinese Communities.

Authors:  Justin Chin; Sarah Li; Gregory Yim; YaQun Arlene Zhou; Peter Justin Wan; Emily R Dube; Mikhail Volokitin; Sonu Sahni; Mark A Terrell; Christine M Lomiguen
Journal:  Fam Med Community Health       Date:  2020-02-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.